CRISPR-Cas9 screening identifies an IRF1-SOCS1-mediated negative feedback loop that limits CXCL9 expression and antitumor immunity-Reference-Cited by-同舟云学术

CRISPR-Cas9 screening identifies an IRF1-SOCS1-mediated negative feedback loop that limits CXCL9 expression and antitumor immunity

Published:2023-08 Issue:8 Volume:42 Page:113014
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

House Imran G.,Derrick Emily B.,Sek Kevin,Chen Amanda X.Y.,Li Jasmine,Lai Junyun,Todd Kirsten L.,Munoz Isabelle,Michie Jessica,Chan Cheok Weng,Huang Yu-Kuan,Chan Jack D.,Petley Emma V.,Tong Junming,Nguyen DatMinh,Engel Sven,Savas Peter,Hogg Simon J.,Vervoort Stephin J.,Kearney Conor J.,Burr Marian L.,Lam Enid Y.N.,Gilan Omer,Bedoui Sammy,Johnstone Ricky W.,Dawson Mark A.,Loi Sherene,Darcy Phillip K.,Beavis Paul A.

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference69 articles.

1. Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma;Larkin;N. Engl. J. Med.,2019

2. Nivolumab plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer;Hellmann;N. Engl. J. Med.,2019

3. PD-1 blockade induces responses by inhibiting adaptive immune resistance;Tumeh;Nature,2014

4. Intratumoral Activity of the CXCR3 Chemokine System Is Required for the Efficacy of Anti-PD-1 Therapy;Chow;Immunity,2019

5. Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade;House;Clin. Cancer Res.,2020

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SOCS1 is a critical checkpoint in immune homeostasis, inflammation and tumor immunity;Frontiers in Immunology;2024-06-14

2. Adaptor molecules mediate negative regulation of macrophage inflammatory pathways: a closer look;Frontiers in Immunology;2024-02-28

3. Pharmacological Polarization of Tumor‐Associated Macrophages Toward a CXCL9 Antitumor Phenotype;Advanced Science;2024-02-11

4. Roles of Interferon Regulatory Factor 1 in Tumor Progression and Regression: Two Sides of a Coin;International Journal of Molecular Sciences;2024-02-10

5. CRISPR-Cas9 screening identifies an IRF1-SOCS1-mediated negative feedback loop that limits CXCL9 expression and antitumor immunity;Cell Reports;2024-02